Curative Biotechnology, Inc.
CUBT
$0.0115
-$0.0003-2.54%
09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 600.00 | 126.90K | 310.20K | 670.30K | 731.80K |
Total Receivables | -- | -- | -- | 25.00K | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 23.70K | 64.80K | 125.10K | 58.60K | 86.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 24.40K | 191.70K | 435.40K | 753.90K | 817.90K |
|
|||||
Total Current Assets | 24.40K | 191.70K | 435.40K | 753.90K | 817.90K |
Net Property, Plant & Equipment | 6.40K | 6.50K | 6.60K | 6.70K | 2.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 1.63M | 1.63M | 1.59M | 1.56M | 135.40K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 347.90K | 204.00K | 161.70K | 93.00K | -- |
Total Assets | 2.01M | 2.03M | 2.20M | 2.41M | 955.20K |
|
|||||
Total Accounts Payable | 2.20M | 1.35M | 661.70K | 726.90K | 255.60K |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | 846.50K | 581.00K | 155.90K | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 11.50K | 12.60K | 3.40K | 3.40K | -- |
Total Other Current Liabilities | 11.50K | 12.60K | 3.40K | 3.40K | -- |
Total Current Liabilities | 3.06M | 1.95M | 821.10K | 730.30K | 255.60K |
|
|||||
Total Current Liabilities | 3.06M | 1.95M | 821.10K | 730.30K | 255.60K |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 846.50K | 581.00K | 155.90K | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 3.06M | 1.95M | 821.10K | 730.30K | 255.60K |
|
|||||
Common Stock & APIC | 11.92M | 11.65M | 11.65M | 10.56M | 8.64M |
Retained Earnings | -31.04M | -29.62M | -28.34M | -26.92M | -25.03M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -19.12M | -17.98M | -16.69M | -16.36M | -16.39M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 18.07M | 18.07M | 18.07M | 18.04M | 17.09M |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 18.07M | 18.07M | 18.07M | 18.04M | 17.09M |
|
|||||
Total Common Equity | -19.12M | -17.98M | -16.69M | -16.36M | -16.39M |
Total Preferred Equity | 18.07M | 18.07M | 18.07M | 18.04M | 17.09M |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -1.05M | 88.10K | 1.38M | 1.68M | 699.70K |
|